Nasal Vaccines Market, By Vaccine Type (Live attenuated vaccines, Inactivated vaccines, Subunit, Recombinant and Conjugate Vaccines), By Delivery Method, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Nasal Vaccines Market size was valued at USD 418.9 million in 2023, expanding at a CAGR of 8.56% from 2024 to 2032.
Nasal Vaccines Market Dynamics
Nasal vaccines, administered as a spray or mist through the nose, offer a needle-free and potentially more efficient method for inducing immune responses. Their growing preference, particularly among children and needle-phobic individuals, is driving the market forward. Nasal vaccines also have the advantage of inducing mucosal immunity, which can provide enhanced protection against respiratory illnesses. However, challenges such as ensuring vaccine stability and navigating stringent regulatory requirements may act as barriers. Nevertheless, advancements in delivery systems and the development of vaccines for various respiratory diseases, including COVID-19, present exciting opportunities for market growth.
Rising Prevalence of Respiratory Infections Propelling Market Growth
The increasing prevalence of respiratory infections is significantly boosting the nasal vaccine market. Nasal vaccines offer a needle-free alternative to traditional immunization methods, which aligns with the growing preference for less invasive vaccination options. According to the World Health Organization, respiratory infections account for a substantial portion of global mortality, with influenza alone causing an estimated 290,000 to 650,000 deaths annually. This high burden, combined with the advantages of nasal vaccines, is driving market expansion.
Recent studies have demonstrated the effectiveness of nasal vaccines in protecting against respiratory infections. For example, a recent study highlighted the efficacy of a nasal vaccine for respiratory syncytial virus (RSV) in infants, showcasing the potential of this technology. As the fight against respiratory illnesses continues, nasal vaccines are expected to play an increasingly prominent role in improving public health outcomes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NASAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Altimmune Inc.
AstraZeneca PLC
Bharat Biotech International Limited
BioDiem, Inc.
CanSino Biopharmaceuticals Inc.
GlaxoSmithKline plc
Iovance Biotherapeutics, Inc.
Meda Pharma GmbH
MeDiVac, Inc.
Pfizer Inc.
Sanofi S.A.
Seqirus Holdings Pty Ltd
Serum Institute of India Pvt. Ltd.
TransBio Inc.
Vaxlive Inc.
Others
GLOBAL NASAL VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032
Live attenuated vaccines
Inactivated vaccines
Subunit
Recombinant
Conjugate Vaccines
GLOBAL NASAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032
Spray
Drop
GLOBAL NASAL VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032
Public
Private
GLOBAL NASAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Nasal Vaccines Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nasal Vaccines Market Snippet by Vaccine Type
2.1.2. Nasal Vaccines Market Snippet by Delivery Method
2.1.3. Nasal Vaccines Market Snippet by Distribution
2.1.4. Nasal Vaccines Market Snippet by Country
2.1.5. Nasal Vaccines Market Snippet by Region
2.2. Competitive Insights
3. Nasal Vaccines Key Market Trends
3.1. Nasal Vaccines Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nasal Vaccines Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nasal Vaccines Market Opportunities
3.4. Nasal Vaccines Market Future Trends
4. Nasal Vaccines Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nasal Vaccines Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Nasal Vaccines Market Landscape
6.1. Nasal Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nasal Vaccines Market – By Vaccine Type
7.1. Overview
7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
7.1.2. Live attenuated vaccines
7.1.3. Inactivated vaccines
7.1.4. Subunit
7.1.5. Recombinant
7.1.6. Conjugate Vaccines
8. Nasal Vaccines Market – By Delivery Method
8.1. Overview
8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
8.1.2. Spray
8.1.3. Drop
9. Nasal Vaccines Market – By Distribution
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
9.1.2. Public
9.1.3. Private
10. Nasal Vaccines Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Nasal Vaccines Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Nasal Vaccines Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Nasal Vaccines Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Nasal Vaccines Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Nasal Vaccines Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Nasal Vaccines Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Altimmune Inc.
11.2.2. AstraZeneca PLC
11.2.3. Bharat Biotech International Limited
11.2.4. BioDiem, Inc.
11.2.5. CanSino Biopharmaceuticals Inc.
11.2.6. GlaxoSmithKline plc
11.2.7. Iovance Biotherapeutics, Inc.
11.2.8. Meda Pharma GmbH
11.2.9. MeDiVac, Inc.
11.2.10. Pfizer Inc.
11.2.11. Sanofi S.A.
11.2.12. Seqirus Holdings Pty Ltd
11.2.13. Serum Institute of India Pvt. Ltd.
11.2.14. TransBio Inc.
11.2.15. Vaxlive Inc.
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
